Targeting the Tumor Cell Surface in Advanced Prostate Cancer

Surface proteins such as PSMA, B7-H3, STEAP1, DLL3, TROP2, PSCA, HER3, and CD46 are a promising class of novel therapeutic targets in prostate cancer.